Pluristyx

Cell & Gene Therapy · Biotechnology

Overview

Pluristyx provides cell therapy solutions to support the manufacturing and development of custom stem cell products. Provider of induced pluripotent stem cells.

Funding and backers

Total raised
$9.8M
1 round on record
Latest round
$9.8M
Venture round · Jul 2026 · 4 mo ago
Team
11-50
employees, estimated range
The money's age
Fresh money
4 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jul 1 Raised a round Venture round $9.8M · SEC Form D
Funding rounds
RoundDateAmountInvestorsSource
Venture round Jul 2026 $9.8M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Pluristyx Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Benjamin FryerExecutive Officer, DirectorSEC Form D
Jason CarstensExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
F-Prime Capital
backs EurekaBio
Meta Planet
backs Conception
Eight Roads
backs EurekaBio
VU Venture Partners
backs Conception
Compound
backs Conception
UTEC
backs Celaid Therapeutics
Similar startupsby what they do, their industry and backers
Immorta BioVenture round $613k · 2 yr ago · Founded 2023 · 11-50 employees
Immorta Bio is a longevity biotech company developing stem-cell and senescent-cell therapeutics to reverse biological aging and unlock…
BlueWhale BioVenture round $5M · 12 mo ago · Founded 2022
Cell Therapy Success Starts Here Synecta™ Activation and Expansion Solutions.
Celaid Therapeutics
セレイドセラピューティクス - 細胞治療(造血幹細胞). Change the futurewith cell therapy.
APstem Therapeutics
0 APstem is committed to addressing the world's most challenging and currently incurable diseases. APstem was founded on a breakthrough…
Applied CellsFounded 2018 · 11-50 employees
Supporting industry experts in cell therapy development and tumor detection. Discover our column-free cell isolation MARS platforms.
ConceptionVenture round $50k · 2 yr ago · Founded 2018 · 11-50 employees · 4 roles
Conception combines stem cell biology and engineering to create new possibilities for having children.

Financials

Total raised
$9.8M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2026 $9.8M Details

People

Benjamin Fryer
Executive Officer, Director
SEC Form D
Jason Carstens
Executive Officer, Director
SEC Form D
Trent Carrier
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Seattle United States
HQ
How can we help you further your research?
10-50 est. staff
201 Elliott Ave W, Seattle, WA 98119
company site